Humanized Monoclonal Antibody May Be Effective, Safe in Asthma Patients
Medscape January 11, 2011 — Add-on therapy with subcutaneous omalizumab is safe and effective in patients with moderate to severe allergic asthma, according to the … |
View full post on asthma – Google News